Back to News
Market Impact: 0.42

Laureate (LAUR) Q2 2025 Earnings Call Transcript

LAURMSNFLXNVDA
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsCapital Returns (Dividends / Buybacks)Currency & FXEmerging MarketsRegulation & Legislation

Laureate Education posted a strong Q2 with revenue of $524 million and adjusted EBITDA of $214 million, both ahead of guidance, while adjusted EPS came in at $0.79 and management raised full-year 2025 midpoint guidance by $55 million for revenue and $16 million for adjusted EBITDA. Enrollment trends remained healthy, with total enrollments up 6% and new enrollments up 7%, and the company cited a $20 million upside to the quarter largely from FX, plus ongoing growth in Mexico and Peru. Management also highlighted $71 million of year-to-date buybacks, a roughly 150 bps EBITDA margin expansion outlook, and two campus openings scheduled for September.

Analysis

The setup is more interesting than a simple “beat-and-raise.” Laureate is transitioning from a post-COVID capacity-light model to a capital-intense expansion phase, and that usually compresses returns before it expands them. The key second-order issue is whether incremental campus CapEx can sustain the same margin-accretive growth profile once the easy digital mix gains mature; if execution slips, the market will start to treat the new-build pipeline as low-ROIC drags rather than growth optionality. The most underappreciated catalyst is Peru’s online working-adult product. Mexico has already proven that this segment can scale with better capital efficiency and less cyclical demand than traditional undergrad intake; if Peru follows that path, it could become the re-rating mechanism for the next 12-24 months because it converts regulatory change into repeatable, asset-light growth. That also creates a competitive pressure point for smaller private institutions in Peru that lack digital distribution and brand trust — they will likely be forced into price discounting or niche positioning. FX is flattering the optics, but the market should focus on reported cash conversion. Management is signaling roughly 50% EBITDA-to-unlevered FCF conversion even while CapEx rises toward 5% of revenue, which implies the operating engine is still producing excess capital after reinvestment. That combination supports buybacks and should put a floor under the stock on weakness, but it also means the equity can look optically cheap until investors realize reported growth is now partly carrying the burden of funding future campuses. The main risk is timing: the next 1-2 quarters are vulnerable to academic calendar noise, intake execution in Mexico, and any reversal in the peso, which would mechanically unwind part of the guidance raise. If enrollment momentum stalls at the upcoming main intake, the market could re-rate the story from “compounding growth” to “FX-assisted growth with rising capital needs.”